Adamis Pharmaceuticals Corp (ADMP)


Stock Price Forecast

Feb. 7, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Adamis Pharmaceuticals Corp chart...

About the Company

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. The company's SYMJEPI (epinephrine) Injection products are approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis' naloxone injection product candidate, ZIMHI, for the treatment of opioid overdose is currently under FDA review. Adamis is developing additional products, including treatments for acute respiratory diseases, such as COVID-19, influenza, asthma, and COPD. The company's subsidiary, US Compounding Inc., compounds sterile prescription drugs, and certain nonsterile drugs for human and veterinary use by hospitals, clinics, surgery centers, and vet clinics throughout most of the United States. Forward Looking Statements

CEO

Dennis Carlo

Exchange

NASDAQ

Website

www.adamispharmaceuticals.com

$-16M

Total Revenue

15

Employees

$32M

Market Capitalization

-0.31

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ADMP News

Adamis Pharmaceuticals Corporation (ADMP)

2d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Adamis Pharmaceuticals Corp

17d ago, source: Reuters

29 Mar 2023 / 8:00 PM UTCQ4 2022 Adamis Pharmaceuticals Corp Earnings Release 15 May 2023 / 10:59 AM UTCQ1 2023 Adamis Pharmaceuticals Corp Earnings Release ...

Allergy Immunotherapy Market to Set Incredible Growth from Key Players | Circassia, Adamis Pharmaceuticals Corporation, Stallergenes Greer plc

27d ago, source: Digital Journal

A novel research study on Allergy Immunotherapy Market has been recently published by Fior Markets covering the latest trends and key market developments. The report is released with a ...

Fluticasone Market 2023 : Top Countries Data with Growth Rate Competitive Landscape and Forecast To 2028

9d ago, source: MarketWatch

Eupraxia Pharma, Innoviva, Adamis Pharma and Merz Pharma, etc. In 2021, the global top five players have a share approximately in terms of revenue. Global Fluticasone Scope and Segment Fluticasone ...

Stella Pharma Corp Stock (OTC:STPHF), Quotes and News Summary

1d ago, source: Benzinga.com

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT).

Cosmos Pharmaceutical Corp (3349)

2d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

New Suit - Patent

27d ago, source: Law

Counsel have not yet appeared for the defendants. The case is 1:23-cv-00026, Novartis Pharmaceuticals Corporation v. Hec Pharm Co., Ltd. et al.

Phio Pharma Stock (NASDAQ:PHIO), Quotes and News Summary

13d ago, source: Benzinga.com

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and ...

TNXP Tonix Pharmaceuticals Holding Corp.

26d ago, source: Seeking Alpha

The chart has 1 X axis displaying Time. Data ranges from 2022-01-13 00:00:00 to 2023-01-13 00:00:00. The chart has 1 Y axis displaying values. Data ranges from -96.83 to 0.08.

NervGen Pharma Stock (OTC:NGENF), Quotes and News Summary

7d ago, source: Benzinga.com

NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the ...

Inovio Pharmaceuticals Inc.

23d ago, source: Barron's

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Reverse Stock Split

13d ago, source: Finanznachrichten

MARLBOROUGH, Mass., Jan. 25, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL RNAi platform technology is designed ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...